TIL Therapy for Metastatic Ovarian Cancer

NCT02482090 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Ovarian Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: TIL infusion
DRUG: Interleukin-2

Sponsor

Inge Marie Svane